OXFORD ASSET MANAGEMENT LLP - IMMUNE DESIGN CORP ownership

IMMUNE DESIGN CORP's ticker is IMDZ and the CUSIP is 45252L103. A total of 70 filers reported holding IMMUNE DESIGN CORP in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
OXFORD ASSET MANAGEMENT LLP ownership history of IMMUNE DESIGN CORP
ValueSharesWeighting
Q1 2019$1,584,000
+794.9%
270,803
+98.4%
0.04%
+600.0%
Q4 2018$177,000
-47.3%
136,468
+325.9%
0.01%
-16.7%
Q3 2017$336,000
-20.8%
32,039
-26.4%
0.01%
-25.0%
Q2 2017$424,000
-35.9%
43,529
-55.2%
0.01%
-50.0%
Q1 2017$661,000
+17.0%
97,228
-5.3%
0.02%
-20.0%
Q4 2016$565,000
+19.2%
102,692
+76.8%
0.02%
+25.0%
Q2 2016$474,000
-50.1%
58,083
-20.5%
0.02%
-40.7%
Q1 2016$950,000
-18.5%
73,054
+29.9%
0.03%0.0%
Q4 2015$1,166,00056,2480.03%
Other shareholders
IMMUNE DESIGN CORP shareholders Q1 2019
NameSharesValueWeighting ↓
COLUMN GROUP L P 3,161,942$65,294,000100.00%
ProQuest Associates IV LLC 1,983,858$40,967,0008.41%
Iguana Healthcare Management, LLC 150,000$3,098,0000.98%
SECTORAL ASSET MANAGEMENT INC 810,390$16,735,0000.70%
Cormorant Asset Management, LP 189,000$3,903,0000.52%
SPHERA FUNDS MANAGEMENT LTD. 140,000$2,891,0000.28%
RS INVESTMENT MANAGEMENT CO LLC 750,402$15,496,0000.13%
Eventide Asset Management 102,904$2,125,0000.12%
Rock Springs Capital Management LP 55,000$1,136,0000.08%
Focused Wealth Management, Inc 3,406$70,0000.04%
View complete list of IMMUNE DESIGN CORP shareholders